Gene/Event |
Cancer Type |
Patient |
Variant |
Mutation Level |
FLG2 |
Breast Cancer | p143_p2 |
Chr1:152326027:C>G |
Private mutation |
FLG2 |
Breast Cancer | p143_p5 |
Chr1:152326554:C>A |
Trunk mutation |
FLG2 |
Breast Cancer | p143_p5 |
Chr1:152324890:G>C |
Private mutation |
FLG2 |
Colorectal Cancer | p001_PCRC01 |
Chr1:152327032:C>T |
Trunk mutation |
FLG2 |
Colorectal Cancer | p004_CRC_A02 |
Chr1:152323926:T>G |
Private mutation |
FLG2 |
Colorectal Cancer | p155_p229 |
p.G680G |
Private mutation |
FLG2 |
Colorectal Cancer | p155_p495 |
p.S1036* |
Private mutation |
FLG2 |
Esophageal Squamous Cell Carcinoma | p008_ESCC08 |
p.E40V |
Branch mutation |
FLG2 |
Esophageal Squamous Cell Carcinoma | p008_ESCC11 |
p.G2102A |
Branch mutation |
FLG2 |
Esophageal Squamous Cell Carcinoma | p008_ESCC13 |
p.A818S |
Trunk mutation |
FLG2 |
Esophageal Squamous Cell Carcinoma | p124_ESCC012 |
p.S147* |
Private mutation |
FLG2 |
Esophageal Squamous Cell Carcinoma | p124_ESCC012 |
p.S775F |
Private mutation |
FLG2 |
Esophageal Squamous Cell Carcinoma | p124_ESCC029 |
p.Y583* |
Private mutation |
FLG2 |
Esophageal Squamous Cell Carcinoma | p139_EC1020 |
p.R1072H |
Private mutation |
FLG2 |
Esophageal Squamous Cell Carcinoma | p139_EC1120 |
p.S650G |
Branch mutation |
FLG2 |
Gastric Adenocarcinoma | p011_MSS2 |
p.H1667Q |
Private mutation |
FLG2 |
Gastric Carcinoma | p106_GC02 |
p.G965R |
Trunk mutation |
FLG2 |
Gastric Carcinoma | p106_GC07 |
p.T1410T |
Private mutation |
FLG2 |
Gastric Carcinoma | p106_GC07 |
p.G281G |
Private mutation |
FLG2 |
Gastric Carcinoma | p106_GC09 |
p.R1420R |
Private mutation |
FLG2 |
Gastric Carcinoma | p106_GC09 |
p.Q1343R |
Private mutation |
FLG2 |
Gastric Carcinoma | p106_GC15 |
p.S1273R |
Private mutation |
FLG2 |
Gastric Carcinoma | p106_GC15 |
p.S864R |
Private mutation |
FLG2 |
Gastric Carcinoma | p106_GC15 |
p.E1615D |
Private mutation |
FLG2 |
Gastric Carcinoma | p106_GC15 |
p.S1525R |
Private mutation |
FLG2 |
Intrahepatic Cholangiocarcinoma | p159_Pat4 |
p.S2268T |
Trunk mutation |
FLG2 |
Hepatocellular Carcinoma | p061_P02 |
Chr1:152329782:C>G |
Private mutation |
FLG2 |
Hepatocellular Carcinoma | p157_p1 |
p.H1406Q |
Private mutation |
FLG2 |
Lung Adenocarcinoma | p017_472 |
Chr1:152331245:T>A |
Trunk mutation |
FLG2 |
Lung Adenocarcinoma | p083_X472 |
- |
Trunk mutation |
FLG2 |
Medulloblastoma | p072_MB1 |
Chr1:152325479:G>A |
Private mutation |
FLG2 |
Melanoma | p043_C |
p.S717F |
Trunk mutation |
FLG2 |
Melanoma | p043_F |
p.S285L |
Trunk mutation |
FLG2 |
Melanoma | p043_H |
p.R1412K |
Private mutation |
FLG2 |
Melanoma | p043_H |
p.E359K |
Private mutation |
FLG2 |
Ovarian Cancer | p065_patient |
p.E1608K |
Trunk mutation |
FLG2 |
Ovarian Cancer | p144_AOCS088 |
p.G1413G |
Private mutation |
FLG2 |
Prostate Cancer | p105_1027 |
p.Q369X |
Private mutation |
FLG2 |
Prostate Cancer | p164_P2 |
p.S2377X |
Private mutation |
FLG2 |
Urothelial Carcinoma | p031_WCM088 |
p.D1320V |
Private mutation |
FLG2 |
Urothelial Carcinoma | p142_p05 |
- |
Trunk mutation |
FLG2 |
Urothelial Carcinoma | p142_p25 |
- |
Private mutation |
FLG2 |
Urothelial Carcinoma | p142_p37 |
- |
Private mutation |